ReviewCardiology research2023

Glucagon-Like Peptide 1 Receptor Agonists Versus Sodium-Glucose Cotransporter 2 Inhibitors for Atherosclerotic Cardiovascular Disease in Patients With Type 2 Diabetes.

Hidekatsu Yanai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.